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Background and purpose   The appropriate fixation method for 
hemiarthroplasty of the hip as it relates to implant survivorship 
and patient mortality is a matter of ongoing debate. We examined 
the influence of fixation method on revision rate and mortality.
Methods   We analyzed approximately 25,000 hemiarthroplasty 
cases from the AOA National Joint Replacement Registry. Deaths 
at 1 day, 1 week, 1 month, and 1 year were compared for all 
patients and among subgroups based on implant type. 
Results   Patients treated with cemented monoblock hemiar-
throplasty had a 1.7-times higher day-1 mortality compared to 
uncemented monoblock components (p < 0.001). This finding was 
reversed by 1 week, 1 month, and 1 year after surgery (p < 0.001). 
Modular hemiarthroplasties did not reveal a difference in mortal-
ity between fixation methods at any time point. 
Interpretation   This study shows lower (or similar) overall 
mortality with cemented hemiarthroplasty of the hip.
 
 
The frequency of hip fractures is increasing with our ageing 
population, with an annual incidence of between 1.4 and 5 per 
103 per year (Lonnroos et al. 2006, Icks et al. 2008, Varez-
Nebreda et al. 2008). Health model projections have estimated 
that 6.3 million hip fractures will occur annually worldwide 
within the next 40 years (Cooper et al. 1992), imposing a 
significant economic health burden. There is a large reported 
perioperative mortality rate in this population, ranging from 
2.4% to 8.2% at 1 month (Parvizi et al. 2001, Radcliff et al. 
2008) and over 25% at 1 year (Elliott et al. 2003, Jiang et al. 
2005). Furthermore, it was recently reported that the current 
mortality rate is higher now than 25 years ago (Vestergaard et 
al. 2007a). Today, it is generally accepted that displaced intra-
capsular fractures are best treated with arthroplasty rather than 
internal fixation (Keating et al. 2006, Leighton et al. 2007). 
In the at-risk population, however, multiple comorbidities are 
common and the best form of component fixation is in ques-
tion.
Bone cement implantation syndrome is a well-described 
complication of cemented hip arthroplasty. It is characterized 
by a systemic drop in systolic blood pressure, hypoxemia, pul-
monary hypertension, cardiac dysrhythmias, and occasionally 
cardiac arrest and death (Rinecker 1980, Orsini et al. 1987, 
Parvizi et al. 1999). The prevailing theory to explain the patho-
physiology of this phenomenon is embolism of fat, marrow 
contents, bone, and to some degree methylmethacrylate to 
the lung (Rinecker 1980, Elmaraghy et al. 1998, Parvizi et al. 
1999, Koessler et al. 2001). An increased degree of pulmonary 
insult with fat microemboli has been demonstrated (mostly in 
randomized controlled trials) during insertion of a cemented 
femoral stem rather than an uncemented implant (Orsini et al. 
1987, Ries et al. 1993, Christie et al. 1994, Pitto et al. 1999), 
presumably due to increased intramedullary femoral canal 
pressures in the cemented group (Kallos et al. 1974, Orsini et 
al. 1987). These pressures can be reduced by the use of distal 
venting holes in the femur during stem insertion (Engesæter et 
al. 1984). It has been shown previously by single-institutional 
review that patients undergoing cemented hip arthroplasty 
have a higher intraoperative mortality rate relative to unce-
mented arthroplasty, presumably due to a reduced incidence 
of fat embolism in the latter group (Parvizi et al. 1999). The 
increased mortality risk was also present at 30 days in the treat-
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studies have been unable to identify any increased mortality 
risk with the use of cement (Lausten and Vedel 1982 (obser-
vational), Emery et al. 1991 (RCT), Lo et al. 1994 (observa-
tional), Khan et al. 2002a,b (literature review), Parker and 
Gurusamy 2004 (literature review)) and others have shown a 
decrease in mortality at 30 days when cement is used (Foster 
et al. 2005). 
Cemented hip hemiarthroplasty appears to offer improved 
rate of return to baseline function, reduced postoperative pain, 
and superior long-term survivorship relative to uncemented 
arthroplasty (Khan et al. 2002a, b, Parker and Gurusamy 
2004). We reasoned that failure to return to baseline function 
after hemiarthroplasty may be another risk factor for periop-
erative mortality (Hannan et al. 2001, Braithwaite et al. 2003). 
Lower revision rates for cemented prostheses and increased 
mortality at revision surgery contribute further to reducing the 
overall mortality risk. We evaluated the relationship between 
the method of fixation of hip arthroplasty and perioperative 
mortality using a large national joint replacement registry.
Patients and methods
Data pertaining to patient age, implant type, fixation method, 
and patient location were obtained from the Australian Ortho-
paedic Association (AOA) National Joint Replacement Reg-
istry (NJRR). Mortality information was obtained by patient 
matching with the National Death Index (NDI) from the Aus-
tralian Institute of Health and Welfare. The outcome of inter-
est was mortality at 1 day, 1 week, 1 month, and 1 year after 
surgery. Data were then stratified by implant type to examine 
the effect of cement fixation within monoblock and modular 
implant procedures.
The AOA NJRR identified patient selection differences for 
implant type based on demographic data. As patient comor-
bidities are not captured in the AOA NJRR, these demograph-
ics were used as a surrogate measure for different patient pop-
ulations in an effort to adjust for bias in the comparison of fix-
ation method. We hypothesized that monoblock components 
are usually reserved for more elderly, lower-demand patients 
with more comorbidities and that modular prosthesis implants 
are used in healthier patients with expected longer survival. 
Data in the AOA NJRR are collected at the time of surgery 
using a standard paper-based form, with methods described 
in more detail elsewhere (Conroy et al. 2008, AOA 2009). 
Each hospital subsequently forwards these forms to the regis-
try for data entry. Forms with incomplete or inconsistent data 
are followed up by the registry with the hospital concerned. 
Cases where forms have not been completed are identified by 
verification of registry data using government hospitalization 
separation data. 
Statistics
Mortality rates were compared between cemented and unce-
mented prostheses using a time-dependent Cox proportional-
hazards model. For each model, the assumption of proportional 
hazards was checked analytically by inspecting the graph of 
log(log(survival)) plotted against log of survival time. Time 
points were selected a priori based on clinical importance, 
and hazard ratios were then calculated for each selected time 
period. All analyses were adjusted for age and sex as mea-
sured at the date of the primary procedure. All analyses were 
performed using SAS software version 9.1. 
Ethics
Local ethical approval was not required from our institution, 
as this study was purely data-driven and used de-identified 
national data. A formal request was made to the Australian 
Orthopaedic Association (AOA) National Joint Replacement 
Registry (NJRR) for access to the national de-identified data. 
Results
Patient demographics
12,804 patients were treated with uncemented hemiarthro-
plasty and 12,935 were treated with cemented hemiarthro-
plasty. No statistically significant differences in demographic 
characteristics between the methods of fixation were detected 
among the different groups (Table 1).
Table 1. Patient demographics for hemiarthroplasty procedures
Type of Total Age % Females
component < 70 71–80 > 80
Monoblock
 Cemented 3,634    169 (4.7%)    946 (26.0%)   2,519 (69.3%) 74
 Uncemented 10,362    420 (4.1%) 2,550 (24.6%)   7,392 (71.3%) 74
 Subtotal 13,996    589 3,496   9,911
Modular
 Cemented 9,301 1,518 (16.3%) 3,233 (34.8%)   4,550 (49.6%) 74
 Uncemented 2,442    446 (18.3%)    750 (30.7%)   1,246 (51.0%) 72
 Subtotal 11,743 1,964 3,983   5,796
Total 25,739 2,553 7,479 15,707
a single-institutional review (Par-
vizi et al. 2004). Although cement-
related mortality is rare (Dearborn 
and Harris 1998, Parvizi et al. 1999, 
2001, 2004, Weinrauch et al. 2006), 
it is a devastating complication—
often reported through observational 
studies or literature reviews. Propo-
nents of uncemented hip arthroplasty 
often cite this concern to support 
their reluctance to use cemented hip 
arthroplasty in both elective pro-
cedures and fracture management. 
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Perioperative mortality
Kaplan Meier survival estimates by postoperative days are 
shown in Figure 1 and hazard ratios are detailed in Table 
2. There was an increased risk of perioperative mortality in 
patients treated with uncemented hemiarthroplasty at 1 week 
(p = 0.02), 1 month (p = 0.03), and 1 year (p < 0.001) post-
operatively. Conversely, there was a greater risk of periopera-
tive mortality in the first postoperative day in patients treated 
with cemented components (p < 0.001), suggesting that at-risk 
patients are more likely to succumb early if cement is used. 
However, most patients receiving cemented components were 
treated with modular components (9,301 of 12,935; 72%), 
whereas most patients receiving uncemented components 
received a monoblock prosthesis (10,362 of 12,804; 81%). We 
were therefore interested in further characterizing the role of 
fixation method in different patient groups, to identify the true 
effect of cement on mortality.
Cemented vs. uncemented monoblock components
10,362 patients were treated with uncemented monoblock 
implants and 3,634 patients received cemented monob-
lock implants. The mortality rate was higher at day 1 when 
cemented monoblock implants were used (p < 0.001). This 
has been further detailed—per day for the first postoperative 
week—in Table 3. However, this difference between groups 
was no longer statistically significant at 1 week or 1 month. By 
1 year, the death rate had reversed with a favorable survival for 
patients treated with cemented implants (p < 0.001) (Figure 2 
and Table 4). 
Figure 1. All-cause mortality in cemented and uncemented hemiarthro-
plasty patients.
Table 2. Hazard ratios (HRs) for risk of death, according to kind of fixation, 
for all hemiarthroplasties
 HR (95% CI) p-value No. of deaths 
 (cementless   Cemented Cementless
 vs. cemented)  (n = 12,935)   (n = 12,804)
1 day 0.59 (0.43–0.79) 0.0005 109 70
1 week 1.36 (1.05–1.74) 0.02 345 384
1 month 1.27 (1.03–1.58) 0.03 860 1,170
1 year 1.37 (1.29–1.49) < 0.001 2,680 3,794
Table 3. Hazard ratios (HRs) for day of operation to day 6 for risk of death, according to kind of fixation, for monoblock hemiarthro-
plasty
 Cemented Cementless   
  No. at risk Deaths Cumulative  No. at risk Deaths Cumulative HR (95% CI) 
 at  start  survival (95% CI) at start  survival (95% CI) (cementless
 of period   of period   vs. cemented)
0 3,634 0 100 10,362 0 100  
1 3,582 46   99.3 (99.0–99.6) 10,299 62   99.9 (99.8–99.9) 0.47 (0.32–0.68)
2 3,557 70   98.7 (98.3–99.0) 10,258 102   99.4 (99.2–99.5) 0.57 (0.35–0.95)
3 3,540 85   98.1 (97.6–98.5) 10,196 161   99.0 (98.8–99.2) 1.35 (0.76–2.37)
4 3,524 100   97.7 (97.1–98.1) 10,143 212   98.4 (98.2–98.7) 1.17 (0.66–2.07)
5 3,508 113   97.2 (96.7–97.7) 10,092 259   98.0 (97.7–98.2) 1.24 (0.67–2.29)
6 3,497 123   96.9 (96.3–97.4) 10,055 295   97.5 (97.2–97.8) 1.24 (0.61–2.49)




































278 Acta Orthopaedica 2011; 82 (3): 275–281
As comorbidities increase with age, we hypothesized that if 
cement was a risk factor for perioperative mortality, the rela-
tionship would be more evident in the elderly patients treated 
with cemented hemiarthroplasty. To investigate this relation-
ship, we analyzed this cohort of patients further, stratified by 
age and according to whether they were treated with cemented 
or uncemented hemiarthroplasty. Although the numbers were 
relatively small (see Table 1), this analysis showed that elderly 
patients (> 70 years old) had a more favorable survivorship at 
1 year when cemented monoblocks were compared to unce-
mented monoblocks (Figure 3) (p = 0.005 (patients 71–80 
years old) and p < 0.001 (patients > 80 years old)). In the older 
age group (> 80), there was a higher 1-day mortality rate when 
cement was used (p < 0.001), but the significance of this dif-
ference was not apparent by 1 week (p = 0.5) or by 1 month (p 
= 0.9). The situation was even reversed by 1 year (p < 0.001), 
when cemented implants had a more favorable mortality rate.
Cemented vs. uncemented modular components
2,442 patients were treated with uncemented modular com-
ponents, while 9,301 received cemented implants. There was 
no statistically significant difference in mortality at any time 
between the methods of fixation of modular implants (Table 5 
and Figure 4).
Discussion
Compared to uncemented procedures, we found reduced 
mortality at 1 year following a cemented procedure. At the 
outset of this study, it was our hypothesis that there would be 
similar mortality rates for cemented and uncemented hemi-
arthroplasty using a large, nationwide joint registry database. 
The fact that the data revealed a lower overall mortality rate at 
later times with cemented monoblock procedures was surpris-
ing. Together with the fact that implant survival from the AOA 
NJRR is increased for cemented implants than for uncemented 
implants into the medium term (AOA 2009) and the existence 
of previous work demonstrating improved functional outcome 
and pain scores with cemented implants (Khan et al. 2002a,b, 
Parker and Gurusamy 2004), it is becoming increasingly dif-
ficult to justify the continued preference of some surgeons for 
uncemented implants.
The strength of this study lies in the large numbers that were 
available for analysis. Due to high data completion rates and 
stringent data validation protocols by the AOA NJRR, the data 
are robust and easily lend themselves to this type of analysis.
There are many possible explanations for our findings. 
Firstly, a weakness of this study is that selection of implant 
fixation was not randomized. In that regard, other patient 
Table 4. Hazard ratios (HRs) for risk of death, according to kind of fixation, 
for monoblock hemiarthroplasty
 HR (95% CI) p-value No. of deaths 
 (cementless   Cemented Cementless
 vs. cemented)  (n = 3,634)    (n = 10,362)
1 day 0.47 (0.32–0.68) < 0.001 46 62
1 week 1.16 (0.81–1.66) 0.4 138 340
1 month 0.95 (0.71–1.26) 0.7 359 1,051
1 year 1.23 (1.13–1.34) < 0.001 1,015 3,413
Figure 3. All-cause mortality in cemented and uncemented monoblock 
hemiarthroplasty patients stratified by age.
Table 5. Hazard ratios (HRs) for risk of death, according to kind of fixation, 
for modular hemiarthroplasty
 HR (95% CI) p-value No. of deaths 
 (cementless   Cemented Cementless
 vs. cemented)  (n = 9,301) (n = 2,442)
1 day 0.48 (0.23–1.01) 0.05 63 8
1 week 1.18 (0.70–7.97) 0.5 207 44
1 month 0.91 (0.55–1.49) 0.7 501 119
1 year 0.89 (0.78–1.02)  0.09 1,665 381
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factors may have influenced the surgeon’s decision to avoid 
cement, which may not have been adequately adjusted for in 
our analysis. For example, it has been shown that pre-existing 
cardiac disease is an independent risk factor for cement-related 
mortality (Parvizi et al. 2004). Other risk factors for increased 
perioperative mortality with hip fracture include age, sex, and 
comorbidities (Hannan et al. 2001, Jiang et al. 2005, Vester-
gaard et al. 2007b, Varez-Nebreda et al. 2008). The Australian 
Orthopaedic Association National Joint Replacement Regis-
try does not collect comorbidity data, and in that regard we 
could not rule out the possibility that selection bias for fixation 
method influenced overall patient mortality. Our subcatego-
rization of procedures into modular and monoblock compo-
nents was an effort to control for this variable with a surrogate 
measure, as monoblock components are typically used in the 
frail elderly for quicker surgery and as there is less functional 
demand on the component postoperatively.
In a separate analysis, we found that there was a favor-
able survival rate at 1 year in patients aged 71–80 and > 80 
when cemented monoblock implants were used rather than 
uncemented monoblock components. The reasons for this are 
unclear, but they may relate to selection of fixation method 
based on patient variables not captured by the AOA NJRR. For 
example, it is possible that elderly patients receiving cemented 
monoblock components are generally in better health than 
those treated with uncemented monoblock hemiarthroplasty, 
and are felt to be less likely to succumb to cement-related drop 
in systolic blood pressure intraoperatively. Alternatively, the 
opposite may be true—as for hip prostheses, generally fitter 
(younger, healthier) individuals receive cementless prostheses. 
There is also considerable state-to-state variability in prefer-
ence for fixation method (AOA 2009), and individual hospital 
trends, which probably reflect different training and philoso-
phies across the country. Further subanalysis of the relation-
ship of these variables makes broad conclusions difficult, as 
patient numbers decrease with further subcategorization.
The cause of death was also not investigated in this study; 
thus, we could not directly link mortality to surgery-related 
issues. Certainly, 1-day and 1-week mortality are likely to 
be associated with perioperative factors. Consistent with our 
study, Foster et al. (2005) found a higher 30-day mortality rate 
in uncemented (9%) vs. cemented (1%) hemiarthroplasties in 
a retrospective review of 244 patients, despite similar ASA 
grades in both groups.
Parker and Gurusamy (2004) published a meta-analysis on 
the outcome of cemented hip arthroplasties vs. uncemented 
components for hip fracture, and found that mobility and pain 
at 1 year postoperatively was better in the cemented group. 
There was no difference in perioperative mortality in their 
analysis. This report included over 1,900 patients, although 
still substantially smaller than our study. The same findings 
were corroborated in a separate meta-analysis of 18 publica-
tions comparing cemented and uncemented arthroplasty for 
hip fractures (Khan et al. 2002b). Khan’s group further com-
pared 121 uncemented to 123 cemented Austin-Moore hemi-
arthroplasty patients done in 2 hospitals (Khan et al. 2002a). 
Patients treated with uncemented Austin-Moore implants had 
more pain, worse function in terms of walking and dependence 
on walking aids, and reduced capacity to perform activities of 
daily living compared to patients with cement fixation. There 
was no statistically significant difference in mortality or non-
fatal medical complication rates related to type of fixation used. 
There were more intraoperative fractures (3/121 uncemented 
vs. 0/123 cemented), more dislocations (3/121 vs. 0/123), and 
a higher failure rate (numbers not reported) in patients with 
uncemented implants. In a single-institution audit, Singh and 
Deshmukh (2006) reported a higher overall reoperation and 
revision rate using uncemented Austin-Moore implants than 
when using cemented Thompson hemiarthroplasties. Patients 
treated with cemented implants also had a higher overall sat-
isfaction rate relative to those with the uncemented stem. In 
a small, randomized study comparing cemented Thompson 
implants to uncemented Austin-Moore implants (Emery et al. 
1991), pain and dependence on walking aids was less if the 
femoral component was fixed with cement. There was no dif-
ference in mortality or perioperative complications in either 
group. In a retrospective review of 107 patients treated with 
Thompson hemiarthroplasty for displaced femoral neck frac-
tures, Sikorski and Millar (1977) failed to demonstrate any 
increased rate of mortality, myocardial infarction, cerebrovas-
cular incident, cardiac failure, or postoperative hypotension 
whether or not cement was used. Similar findings have been 
reported with other comparisons of cemented and uncemented 
implants (Lausten and Vedel 1982, Lo et al. 1994).
Although pulmonary fat embolization is much less common 
with uncemented components, embolic events do occur 
(Orsini et al. 1987, Ries et al. 1993, Pitto et al. 1999), and 
this is probably related to increased intramedullary pres-
sures during instrumentation of the femoral canal (Kallos et 
al. 1974, Orsini et al. 1987). Wenda et al. (1995) showed that 
reaming of the intramedullary canal produces pressures aver-
aging 835 mmHg, and that only 200 mmHg is required for 
fat intravasation and embolization. This compares with maxi-
mum pressures of approximately 846 mmHg, demonstrated 
with introduction of cement into the femoral canal in a dog 
model by Orsini et al (1987). In fact, there have been a few 
case reports outlining perioperative fat embolism syndrome 
and mortality due to fat embolization with uncemented hip 
arthroplasty (Arroyo et al. 1994, Gelinas et al. 2000). It is also 
known that intraoperative complications are higher with unce-
mented hemiarthroplasty, including iatrogenic femoral frac-
ture (Foster et al. 2005, Weinrauch et al. 2006). A randomized, 
controlled trial investigating the prevalence of fat and bone 
marrow emboli in the lung based on right-atrium blood sam-
pling showed similar prevalences with cemented and unce-
mented components (Kim et al. 2002). Furthermore, it has 
been shown that proper femoral canal lavage and vacuum suc-
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tie et al. 1995, Pitto et al. 1998). Modern cement techniques 
may therefore account for the lower incidence of perioperative 
mortality with use of cement compared to earlier studies.
In conclusion, this study shows a small but statistically sig-
nificantly increased risk of mortality at 1 day when cement is 
used for monoblock hemiarthroplasty procedures. By 1 week, 
there is no longer a mortality advantage to avoiding cement, 
and by 1 year, mortality is less when cement is used. This 
may be due to a higher overall revision rate with uncemented 
monoblock components. When modular components are com-
pared, there is no difference in mortality at any time analyzed, 
although there is a higher implant revision rate when unce-
mented components are used. These data support the use of 
cemented hemiarthroplasty components in patients with hip 
fracture.
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cal analysis and edited the manuscript. RWC conceived the study and edited 
the manuscript.
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